AL HJR76

Urges President Biden, the U.S. Congress, the Food and Drug Administration, and relevant federal agencies to encourage increased manufacture of essential drugs within the United States using reasonable means.

Cites COVID-19 pandemic as revealing the danger of U.S. dependence on foreign drug manufacturing, noting that approximately 90 percent of antibiotics consumed in the United States are manufactured in China or other foreign countries.

States that reliance on foreign countries for essential drugs is dangerous, particularly during pandemics and when dealing with potentially hostile nations.

Requires copies of the resolution be delivered to President Biden, members of the Alabama Congressional Delegation, and the Commissioner of Food and Drugs to communicate the legislature's position on this issue.

Resolution was adopted by the House of Representatives on March 3, 2021, and by the Senate on March 9, 2021.